Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd. (Evofuel). It operates through two segments. Its Evogene segment develops seed traits, ag-chemical products, and ag-biological products to improve plant performance. The Company's Evofuel segment develops species of the castor bean plant for second generation feedstock for biofuel and other industrial uses. Its Crop Enhancement (CE) division is developing two types of products: CE seed traits, are seed traits having improved yield and abiotic stress tolerance, and ag-biologicals, which focuses on microbial-based bio-stimulants. The Company's Crop Protection (CP) division is developing two types of products: CP seed traits and ag-chemicals.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Symbol: NYSE:EVGN
- CUSIP: N/A
- Web: www.evogene.com
- Market Cap: $135.94 million
- Outstanding Shares: 25,626,000
- 50 Day Moving Avg: $5.20
- 200 Day Moving Avg: $5.28
- 52 Week Range: $4.86 - $7.09
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -35.37
- P/E Growth: 0.0000
- Annual Revenue: $5.24 million
- Price / Sales: 25.94
- Book Value: $3.25 per share
- Price / Book: 1.63
- EBIDTA: ($19,530,000.00)
- Net Margins: -235.47%
- Return on Equity: -18.60%
- Return on Assets: -17.16%
- Current Ratio: 17.05%
- Quick Ratio: 17.04%
- Average Volume: 6,825 shs.
- Beta: 0.61
- Short Ratio: 0.64
Frequently Asked Questions for Evogene Ltd (NYSE:EVGN)
What is Evogene Ltd's stock symbol?
Evogene Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVGN."
How were Evogene Ltd's earnings last quarter?
Evogene Ltd (NYSE:EVGN) issued its earnings results on Wednesday, May, 17th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.01. The firm earned $0.72 million during the quarter. Evogene Ltd had a negative return on equity of 18.60% and a negative net margin of 235.47%. View Evogene Ltd's Earnings History.
Where is Evogene Ltd's stock going? Where will Evogene Ltd's stock price be in 2017?
1 equities research analysts have issued 1 year target prices for Evogene Ltd's stock. Their forecasts range from $10.00 to $10.00. On average, they expect Evogene Ltd's stock price to reach $10.00 in the next year. View Analyst Ratings for Evogene Ltd.
Who are some of Evogene Ltd's key competitors?
Some companies that are related to Evogene Ltd include SIGA Technologies (SIGA), Kamada Ltd (KMDA), Compugen (CGEN), Curis (CRIS), Akebia Therapeutics (AKBA), Cerus (CERS), Anavex Life Sciences Corp. (AVXL), Idera Pharmaceuticals (IDRA), Aratana Therapeutics (PETX), Abeona Therapeutics (ABEO), Ardelyx (ARDX), Chimerix (CMRX), Corium International (CORI), Codexis (CDXS), Cascadian Therapeutics (CASC), Immune Design Corp (IMDZ), Cempra (CEMP) and Fortress Biotech (FBIO).
Who owns Evogene Ltd stock?
Evogene Ltd's stock is owned by a variety of of institutional and retail investors. Top institutional investors include UBS Group AG (4.13%), Bank of America Corp DE (3.28%), Goldman Sachs Group Inc. (2.36%), Clal Insurance Enterprises Holdings Ltd (2.35%), Vanguard Group Inc. (1.64%) and Canada Pension Plan Investment Board (1.10%). View Institutional Ownership Trends for Evogene Ltd.
Who sold Evogene Ltd stock? Who is selling Evogene Ltd stock?
Who bought Evogene Ltd stock? Who is buying Evogene Ltd stock?
Evogene Ltd's stock was purchased by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., UBS Group AG, JPMorgan Chase & Co., Bank of America Corp DE, Jane Street Group LLC and Vanguard Group Inc.. View Insider Buying and Selling for Evogene Ltd.
How do I buy Evogene Ltd stock?
Shares of Evogene Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Evogene Ltd stock cost?
One share of Evogene Ltd stock can currently be purchased for approximately $5.30.
Consensus Ratings for Evogene Ltd (NYSE:EVGN) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$10.00 (88.51% upside)|
Analysts' Ratings History for Evogene Ltd (NYSE:EVGN)
(Data available from 5/27/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|8/17/2016||Credit Suisse Group AG||Lower Price Target||Outperform||$19.00 -> $10.00||N/A|
|11/19/2015||Piper Jaffray Companies||Lower Price Target||Neutral||$12.00 -> $8.00||N/A|
Earnings History for Evogene Ltd (NYSE:EVGN)Earnings History by Quarter for Evogene Ltd (NYSE:EVGN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/11/2016||Q2||($0.11)||($0.18)||$5.36 million||$3.82 million||View||Listen|
|5/19/2016||Q1||($0.11)||($0.13)||$2.70 million||$2.00 million||View||Listen|
|3/1/2016||Q415||($0.17)||($0.22)||$3.90 million||$2.46 million||View||N/A|
|11/18/2015||Q315||($0.15)||($0.13)||$3.50 million||$3.31 million||View||Listen|
|8/5/2015||Q215||($0.19)||($0.20)||$4.40 million||$2.66 million||View||N/A|
|5/19/2015||Q115||($0.20)||($0.13)||$3.65 million||$2.70 million||View||Listen|
|11/10/2014||Q314||($0.10)||($0.17)||$4.20 million||$3.16 million||View||N/A|
|8/20/2014||Q214||($0.11)||($0.13)||$4.77 million||$3.85 million||View||N/A|
|5/7/2014||Q1 14||($0.13)||($0.09)||$5.40 million||$3.86 million||View||N/A|
|3/19/2014||Q413||($0.08)||($0.20)||$4.95 million||$4.41 million||View||N/A|
Earnings Estimates for Evogene Ltd (NYSE:EVGN)
Current Year EPS Consensus Estimate: $-0.6600 EPS
Next Year EPS Consensus Estimate: $-0.1500 EPS
Dividend History for Evogene Ltd (NYSE:EVGN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Evogene Ltd (NYSE:EVGN)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Evogene Ltd (NYSE:EVGN)
Latest Headlines for Evogene Ltd (NYSE:EVGN)
Evogene Ltd (EVGN) Chart for Saturday, May, 27, 2017